0
Article |

Behavioral Treatment of Hyperkinesis

WILLIAM E. PELHAM, MA
Am J Dis Child. 1976;130(5):565. doi:10.1001/archpedi.1976.02120060111020.
Text Size: A A A
Published online

Concerns have recently been expressed about pharmacological intervention in the treatment of hyperkinesis. Increases in heart rate and blood pressure,1.2 and a decrease in growth rate3 have been reported, and there are serious questions regarding the long-term effectiveness of pharmacotherapy.4 The following case illustrates the effectiveness of behavioral psychotherapy in a child with hyperkinesis.

Report of a Case.—A 9-year-old boy had been diagnosed as hyperkinetic and had received medication since age 6. Initially, he received 20 mg methylphenidate hydrochloride in the morning and 10 mg after school. The boy's problems consisted of noncompliance with teacher and parental requests, teasing and fighting with siblings and classmates, and failure to complete academic tasks and homework. Treatment involved establishing a behavioral intervention program in home and school, while concurrently withdrawing the methylphenidate.

Therapy, which was approached through a combination of assigned readings,5 discussion and feedback, and videotaped interactions,

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs